drugset / Trial / NCT01824758

Effect of Esmolol on Pain Due to Rocuronium

NCT01824758

Phase 4 Completed 90 enrolled Ankara Diskapi Training and Research Hospital
RandomizedParallel-groupDouble-blindSupportive care

Summary

90 American society of anesthesiology (ASA) physical status I and II patients undergoing general anesthesia for elective surgery will be included in the study. Patients will be randomized into three groups. Group E will receive esmolol (1 mg/kg), Group IL lidocaine (0.5 mg/kg)and Group C placebo(NaCl 0.9%, 5 mL), followed by a 0.05 mg/kg rocuronium. After intravenous induction with propofol, adequate muscle relaxation for intubation will be received by 0.5 mg/kg rocuronium.

Timeline

Start
2013-03
Primary completion
2013-04
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Esmolol Other / unclassified 1 mg/kg
Comparator Lidocaine Other / unclassified 0.5 mg/kg
Background Rocuronium Other / unclassified 0.05 mg/kg

Indications

No indication recorded.